UAE Strengthens access to innovative care with New Fibrosis Drug Approval
The Emirates Drug Establishment has approved Jascayd® (nerandomilast) for the treatment of…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
Emirates Drug Establishment Recalls Select Nestlé Infant Formula Batches Across UAE Over Safety Concerns
The Emirates Drug Establishment has initiated a precautionary recall of select Nestlé…
UAE: EDE recalls “Hong Thai Herbal Inhaler (Yadom)” from local markets due to microbial contamination
The Emirates Drug Establishment (EDE) has ordered the withdrawal of the “Hong…
4th Emirates Health Economics Conference Wraps Up, Highlights Global Healthcare Financing
Dubai, UAE- October 2024- The 4th Emirates Health Economics Society (EHES) Annual…
